These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Targeting the residual cardiovascular risk by specific anti-inflammatory interventions as a therapeutic strategy in atherosclerosis. Hafiane A; Daskalopoulou SS Pharmacol Res; 2022 Apr; 178():106157. PubMed ID: 35257900 [TBL] [Abstract][Full Text] [Related]
6. The Emerging Role of Inflammation in Cardiovascular Disease. Martinez BK; White CM Ann Pharmacother; 2018 Aug; 52(8):801-809. PubMed ID: 29557210 [TBL] [Abstract][Full Text] [Related]
7. The Role of Suppressing Inflammation in the Treatment of Atherosclerotic Cardiovascular Disease. Roman YM; Hernandez AV; White CM Ann Pharmacother; 2020 Oct; 54(10):1021-1029. PubMed ID: 32425120 [TBL] [Abstract][Full Text] [Related]
8. Evolving Management of Low-Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum. Wilkinson MJ; Lepor NE; Michos ED J Am Heart Assoc; 2023 Jun; 12(11):e028892. PubMed ID: 37260036 [TBL] [Abstract][Full Text] [Related]
9. Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options. Berman AN; Blankstein R Curr Cardiol Rep; 2019 Aug; 21(9):110. PubMed ID: 31378838 [TBL] [Abstract][Full Text] [Related]
17. Most important advances in preventive cardiology during this past decade: Viewpoint from the American Society for Preventive Cardiology. Wong ND; Toth PP; Amsterdam EA; Trends Cardiovasc Med; 2021 Jan; 31(1):49-56. PubMed ID: 31882264 [TBL] [Abstract][Full Text] [Related]
18. An Update on Inflammation in Atherosclerosis: How to Effectively Treat Residual Risk. Mohammadnia N; Opstal TSJ; El Messaoudi S; Bax WA; Cornel JH Clin Ther; 2023 Nov; 45(11):1055-1059. PubMed ID: 37716836 [TBL] [Abstract][Full Text] [Related]